You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liver Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Liver Cell Carcinoma
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • +4 more
  • Transarterial embolization
  • Microwave Ablation
  • Charlotte, North Carolina
    Carolinas Medical Center
Apr 20, 2022

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 30, 2023

Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

Terminated
  • Metastatic Pancreatic Carcinoma
  • CAR2 Anti-CEA CAR-T cells
  • Providence, Rhode Island
    Roger Williams Medical Center
Jan 12, 2023

Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

Not yet recruiting
  • Liver Diseases
  • +4 more
  • bTAE-HAIC
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 24, 2023

Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

Recruiting
  • Liver Carcinoma
  • Hepatic Cell Carcinoma
  • CAR-GPC3 T cells
  • Wuhan, Hubei, China
    Tao Zhang
Nov 20, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • ECT204 T cells
  • Duarte, California
  • +1 more
Jan 9, 2023

Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma Trial (LioCyx-M, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • (no location specified)
Jan 4, 2022

Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

Recruiting
  • HBV
  • Primary Liver Cancer
  • HBV DNA Sequencing
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 22, 2022

Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Tucson (Social Support Network Intervention, Control (Patient Navigation

Withdrawn
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma
  • Social Support Network Intervention
  • Control (Patient Navigation Service)
  • Tucson, Arizona
    University of Arizona
Nov 15, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))

Completed
  • Hepatocellular Carcinoma
  • TCR-T
  • No intervention and TCR-T (at crossover)
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, Sun-Yat Sen University
Jun 27, 2022

Liver Metastases, NSCLC Trial in Ann Arbor (Liver SBRT, Pembrolizumab)

Recruiting
  • Liver Metastases
  • Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
    Veterans Affairs Ann Arbor Healthcare System
Jul 27, 2022

Breast, Prostate, Colorectal, Liver, or Kidney Cancer or

Recruiting
  • Breast Carcinoma
  • +7 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Rockville, Maryland
    National Cancer Institute Division of Cancer Prevention
Jun 29, 2022

Extensive-stage Small-cell Lung Cancer, Liver Metastases Trial in Los Angeles, Ann Arbor (Bevacizumab)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Liver Metastases
  • Los Angeles, California
  • +2 more
Oct 18, 2022

Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • ET140203 autologous T cell product
  • Duarte, California
  • +3 more
Jul 1, 2022

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

Recruiting
  • Liver Metastases
  • +10 more
  • DNX-2440
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022

Hepatocellular Carcinoma Trial in Wuhan (Nocardia rubra cell wall skeleton, Hepatic arterial infusion chemo, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Nocardia rubra cell wall skeleton
  • +3 more
  • Wuhan, Hubei, China
    Hepatic Surgery Center, Tongji Hospital, Tongji Medical College,
Sep 5, 2022

Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

Recruiting
  • Small-cell Lung Cancer
  • New York, New York
    Columbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

Recruiting
  • Lung Cancer
  • +11 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Anqing, Anhui, China
    The PLA Navy Anqing Hospital
May 23, 2023